Effects of the inducible nitric oxide synthase inhibitor aminoguanidine in two different rat models of schizophrenia-Reference-Cited by-同舟云学术

Effects of the inducible nitric oxide synthase inhibitor aminoguanidine in two different rat models of schizophrenia

Published:2016-08 Issue: Volume:309 Page:14-21
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Lafioniatis Anastasios,Orfanidou Martha A.,Papadopoulou Evangelia S.,Pitsikas Nikolaos

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference81 articles.

1. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development;Akbarian;Arch. Gen. Psychiatry,1993

2. Aniracetam restores object recognition impaired by age, scopolamine and nucleus basalis lesions;Bartolini;Pharmacol. Biochem. Behav.,1996

3. Inducible oxide inhibitors block NMDA antagonist-stimulated motoric behaviors and medial prefrontal cortical glutamate efflux;Bergstrom;Front. Pharmacol.,2015

4. The many faces of nitric oxide in schizophrenia. A review;Bernstein;Schizophr. Res.,2005

5. Nitric oxide and schizophrenia: present knowledge and emerging concepts of therapy;Bernstein;CNS Neurol. Disord. Drug Targets,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of reactive oxygen species production accompanying alternatively activated microglia by risperidone in a mouse ketamine model of schizophrenia;Journal of Neurochemistry;2024-05-21

2. New insights on nitric oxide: Focus on animal models of schizophrenia;Behavioural Brain Research;2021-07

3. Insights into immunopathology and triggering of apoptosis in chronic cerebral toxoplasmosis using murine models;Tropical Biomedicine;2021-04-30

4. Appearance and differentiation of NADPH-d-positive neurons in rat prefrontal cortex following exposure to retinoic acid;Biotechnic & Histochemistry;2020-03-03

5. Meta-analysis of genomic variants and gene expression data in schizophrenia suggests the potential need for adjunctive therapeutic interventions for neuropsychiatric disorders;Journal of Genetics;2019-06